Abstract
In the present study, we explored the prevalence of new psychoactive substance use by people admitted into an Australian acute public mental health facility specializing in comorbid mental health and substance use. These substances have since been banned from retail outlets, but the pattern of uptake and reasons people use them is informative in terms of motivations and the management of substance use more generally. A cross-sectional study to explore the use of synthetic cannabis by people admitted to an acute adult mental health unit was undertaken. Associations with diagnostic, service use, and demographic profiles were explored. Fifty-six percent of people reported having used at least one type of new psychoactive substance, including 53.5% who reported using synthetic cannabis alone, and 18.8% who reported using both synthetic cannabis and other new psychoactive substances. Synthetic cannabis use was not associated with any demographic or diagnostic groups. Legality and availability (43% combined) were common reasons for use, along with the feeling of intoxication (20%). The high prevalence of new psychoactive substance use adds weight to the recommendation that clinicians should routinely screen for substances from the ti...Continue Reading
References
Jan 9, 2010·Schizophrenia Research·Helge MüllerJuan-Manuel Maler
Nov 3, 2010·The American Journal of Emergency Medicine·Christopher RodgmanElizabeth Leimbach
Feb 15, 2011·Drug and Alcohol Dependence·Susanna Every-Palmer
Feb 22, 2011·Drug Testing and Analysis·Simon Hudson, John Ramsey
Apr 13, 2011·The International Journal on Drug Policy·Paul I DarganDavid M Wood
May 14, 2011·Psychosomatics·Dawn M Benford, Jason P Caplan
May 24, 2011·Schizophrenia Research·Nancy Van der Veer, Jason Friday
Jun 28, 2011·Military Medicine·Lucas A JohnsonChris Alfonzo
Sep 24, 2011·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Daniel CastellanosAna Moreno
Oct 5, 2011·The American Journal of Psychiatry·Donald HurstRobert McLay
Feb 9, 2012·Addiction·Monica J Barratt
Mar 7, 2012·The Australian and New Zealand Journal of Psychiatry·Vlasios Brakoulias
Mar 16, 2012·Journal of Psychiatric Practice·Daniel Castellanos, Gabriel Thornton
Apr 13, 2012·The American Journal on Addictions·Stephanie PeglowGregory Briscoe
May 12, 2012·Journal of Mass Spectrometry : JMS·A SalomoneM Vincenti
Oct 10, 2012·Drug and Alcohol Review·Monica J BarrattSimon Lenton
Oct 23, 2012·Journal of Child and Adolescent Psychopharmacology·Olumide O OluwabusiPaul J Ambrosini
Jan 8, 2013·Drug and Alcohol Dependence·Adam R Winstock, Monica J Barratt
Oct 3, 2013·Life Sciences·William E FantegrossiPaul L Prather
Nov 28, 2013·Emergency Medicine Clinics of North America·Michael E NelsonSteven E Aks
Oct 14, 2014·International Journal of Mental Health Nursing·Carole A HarrisonRosemary Hoffman
Aug 25, 2015·International Journal of Mental Health Nursing·Duncan StewartLen Bowers
Feb 8, 2016·Biological Psychiatry·F Markus LewekeCathrin Rohleder
Feb 18, 2016·Drug and Alcohol Dependence·Rachel SutherlandRaimondo Bruno
Citations
Jan 22, 2019·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Jasmin GriggDan I Lubman
Apr 5, 2019·Early Intervention in Psychiatry·Bobby P SmythWalter Cullen
Apr 7, 2020·Current Opinion in Psychiatry·Rachel SutherlandAmy Peacock
Jan 23, 2021·Irish Journal of Psychological Medicine·B P Smyth
Jan 27, 2021·Pharmacology, Biochemistry, and Behavior·Eef L TheunissenJohannes G Ramaekers
Jul 28, 2021·Journal of Cannabis Research·Melissa A JacksonAdrian J Dunlop